Home >> Signaling Pathways >> GPCR/G protein >> Somatostatin Receptor

Somatostatin Receptor

Somatostatin receptor is a G protein-coupled receptor that includes five known somatostatin receptors.

Products for  Somatostatin Receptor

  1. Cat.No. Product Name Information
  2. GC16919 (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 somatostatin sst2 receptor agonist (1R,1'S,3'R/1R,1'R,3'S)-L-054,264  Chemical Structure
  3. GC64665 AGI-41998 AGI-41998 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A). AGI-41998  Chemical Structure
  4. GC64635 AGI-43192 AGI-43192 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A). AGI-43192  Chemical Structure
  5. GC62843 Angiopeptin TFA Angiopeptin TFA, a cyclic octapeptide analogue of somatostatin, is a weak sst2/sst5 receptor partial agonist with IC50 values of 0.26?nM and 6.92?nM, respectively. Angiopeptin TFA  Chemical Structure
  6. GC14119 BIM 23052 sst5 receptor agonist BIM 23052  Chemical Structure
  7. GC16400 BIM 23056 Somatostatin receptor ligand BIM 23056  Chemical Structure
  8. GC62381 BIM-23190 hydrochloride BIM-23190 hydrochloride, a somatostatin analog, a selective SSRT2 and SSRT5 agonist, exhibits Ki values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly. BIM-23190 hydrochloride  Chemical Structure
  9. GC13686 CH 275 Potent somatostatin receptor 1 (sst1) agonist CH 275  Chemical Structure
  10. GC12835 Cortistatin 14 Cortistatin 14 (CST-14, human, rat), a neuropeptide with neuronal depressant and sleep modulating properties, can bind to all five cloned somatostatin receptors (SSTRs) and ghrelin receptor to exert its biological activities and co-exists with GABA within the cortex and hippocampus. Cortistatin 14  Chemical Structure
  11. GC35730 Cortistatin-14 TFA Cortistatin-14 (TFA), a neuropeptide have structural similarity to somatostatin-14, binds and exerts its function via the somatostatin receptors (sst1-sst5). Cortistatin-14 TFA  Chemical Structure
  12. GC15495 Cyclosomatostatin somatostatin receptor antagonist Cyclosomatostatin  Chemical Structure
  13. GC14747 CYN 154806 somatostatin sst2 receptor antagonist CYN 154806  Chemical Structure
  14. GC35787 CYN 154806 TFA CYN 154806 TFA, a cyclic octapeptide, is a potent and selective somatostatin sst2 receptor antagonist, with pIC50 values of 8.58, 5.41, 6.07, 5.76 and 6.48 for human recombinant sst2, sst1, sst3, sst4 and sst5 receptors respectively. CYN 154806 TFA  Chemical Structure
  15. GC36358 J-2156 J-2156 is a high potent, selective somatostatin receptor type 4 (SST4 receptor) agonist with IC50s of 0.05 nM and 0.07 nM for human and rat SST4 receptors, respectively. J-2156  Chemical Structure
  16. GC61413 J-2156 TFA J-2156 TFA is a high potent, selective somatostatin receptor type 4 (SST4 receptor) agonist with IC50s of 0.05 nM and 0.07 nM for human and rat SST4 receptors, respectively. J-2156 TFA  Chemical Structure
  17. GC10181 L-803,087 trifluoroacetate L-803,087 trifluoroacetate is a potent and selective somatostatin sst4 receptor agonist with a Ki of 0.7 nM. L-803,087 trifluoroacetate  Chemical Structure
  18. GC17668 L-817,818 somatostatin sst5 receptor agonist L-817,818  Chemical Structure
  19. GC31349 MK-4256

    MK-4256 is a potent and selective SSTR3 antagonist with IC50s of 0.66 nM and 0.36 nM in human and mouse receptor binding assays, respectively.

    MK-4256  Chemical Structure
  20. GC12448 NNC 26-9100 Somatostatin sst4 receptor agonist NNC 26-9100  Chemical Structure
  21. GC10899 Octreotide acetate A somatostatin receptor agonist Octreotide acetate  Chemical Structure
  22. GC63137 Paltusotine Paltusotine (CRN00808) is an orally active, nonpeptide selective somatostatin type 2 (SST2) receptor agonist. Paltusotine  Chemical Structure
  23. GC10729 Pasireotide stable cyclohexapeptide somatostatin mimic Pasireotide  Chemical Structure
  24. GC62194 Pasireotide acetate Pasireotide (SOM230) acetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). Pasireotide acetate  Chemical Structure
  25. GC36857 Pasireotide ditrifluoroacetate Pasireotide (SOM230) ditrifluoroacetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). Pasireotide ditrifluoroacetate  Chemical Structure
  26. GC36858 Pasireotide L-aspartate salt Pasireotide (SOM230) L-aspartate salt, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). Pasireotide L-aspartate salt  Chemical Structure
  27. GC13758 Seglitide sst2 and sst5 somatostatin receptors agonist Seglitide  Chemical Structure
  28. GC16422 Somatostatin 1-28 Somatostatin receptor agonist Somatostatin 1-28  Chemical Structure
  29. GC65313 SSTR5 antagonist 1 SSTR5 antagonist 1 is a potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonist with IC50s of 9.6 and 57 nM for hSSTR5 and mSSTR5, respectively. SSTR5 antagonist 1  Chemical Structure
  30. GC64259 SSTR5 antagonist 2 hydrochloride SSTR5 antagonist 2 hydrochloride is a highly potent, oral active and selective somatostatin (receptor) subtype 5 (SSTR5) antagonist and has potential for the research of type 2 diabetes mellitus (T2DM). SSTR5 antagonist 2 hydrochloride  Chemical Structure
  31. GC50094 TC-G 1003 TC-G 1003 is a potent somatostatin receptor subtype 2 (sst2) agonist with a Ki value of 0.025 nM and a cAMP IC50 value of 4.8 nM. TC-G 1003  Chemical Structure
  32. GC10328 TT 232 sst1/sst4 somatostatin receptors agonist TT 232  Chemical Structure
  33. GC34130 Vapreotide acetate (RC-160 acetate) Vapreotide acetate (RC-160 acetate) (RC-160 acetate; BMY-41606 acetate) is a neurokinin-1 (NK1) receptor antagonist, with an IC50 of 330 nM. Vapreotide acetate (RC-160 acetate)  Chemical Structure

32 Item(s)

per page

Set Descending Direction